Manipal Health IPO: Temasek-Backed Firm Sets ₹560-590 Price Band

Kalpana Kanungo - Mumbai Bureau Jul 24, 2026 2,300 Views

Manipal Health Enterprises has announced a price band of ₹560-₹590 for its ₹9,276.78 crore IPO, opening July 29, 2026. Backed by Temasek, the hospital chain aims to utilize the proceeds for debt reduction and expansion. This highly anticipated listing is expected to be a key indicator of healthcare investment sentiment.

BENGALURU — Manipal Health Enterprises, one of India’s leading hospital chains, has officially set a price band of ₹560 to ₹590 per share for its upcoming initial public offering (IPO). The Temasek-backed firm, which operates the prominent Manipal Hospitals network, is set to open its subscription window from July 29 to July 31, 2026, marking a significant milestone for the country’s healthcare sector.

The IPO, which aims to raise approximately ₹9,276.78 crore, is expected to play a critical role in the company's long-term growth strategy. Investors can bid for a minimum of 25 shares, with the listing on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) slated for August 5, 2026.

Strategic Expansion and Issue Details

The offering comprises a fresh issue of shares aggregating up to ₹8,001.57 crore and an offer for sale (OFS) of up to 21,613,834 shares, totaling approximately ₹1,275.21 crore. According to company filings, the capital raised from the fresh issue will be primarily utilized for the repayment or prepayment of outstanding borrowings, specifically targeting debt held by its material subsidiary, Manipal Hospitals Private Limited, alongside supporting broader expansion and capital expenditure initiatives.

Manipal Health Enterprises has transformed into one of India’s largest private hospital networks, boasting 49 hospitals across 24 cities with over 12,600 operational beds. The firm’s growth is underpinned by a comprehensive service model that includes tertiary and quaternary care, organ transplants, and advanced diagnostics.

Market Context and Investor Sentiment

The IPO comes at a time of cautious optimism within the Indian equity markets. Despite global geopolitical uncertainties and persistent selling by some foreign institutional investors earlier in the year, the healthcare sector remains a focal point for long-term capital. Market analysts observe that the success of this listing could signal renewed momentum for large-scale public issues in India for the remainder of 2026.

The company has appointed a robust consortium of lead managers, including Kotak Mahindra Capital, Axis Capital, Goldman Sachs, Jefferies, JPMorgan, UBS, and DBS Bank, to oversee the IPO process.

Official Sources Section

The details provided are based on the latest company filings and official reports:

Securities and Exchange Board of India (SEBI): Approved the IPO on July 3, 2026.
Kfin Technologies Limited: Serving as the official registrar for the issue.
Company Filings: Information regarding the price band, lot size, and offer structure.

Quote Section

According to market analysts monitoring the issue:

"The Manipal Health Enterprises IPO represents a landmark event for the Indian healthcare space. By successfully securing SEBI approval and moving to the subscription phase, the firm is well-positioned to leverage its strong network presence to attract institutional and retail interest, despite prevailing market headwinds."

Why It Matters

For investors, this IPO offers a direct stake in one of India’s most established hospital chains, benefiting from the nation's rising demand for high-quality, tech-enabled medical services. For the company, the infusion of capital is essential to reducing leverage and facilitating the expansion of its clinical footprint, ultimately strengthening its position as a preferred healthcare provider.

Key Facts at a Glance

Price Band: ₹560 – ₹590 per equity share.
Subscription Dates: July 29, 2026 – July 31, 2026.
Lot Size: 25 shares (Minimum investment of ₹14,750).
Listing Date: August 5, 2026, on BSE and NSE.
Total Issue Size: Aggregating up to ₹9,276.78 crore.

FAQ Section

1. Where will the Manipal Health Enterprises shares be listed?

The shares are proposed to be listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).

2. What is the primary objective of this IPO?

The funds raised through the fresh issue will primarily be used for debt repayment, including borrowings by its subsidiary, Manipal Hospitals Private Limited, and to fund capital expenditure.

3. Who are the lead managers for the issue?

The issue is managed by a consortium including Kotak Mahindra Capital, Axis Capital, Goldman Sachs, Jefferies, JPMorgan, UBS, and DBS Bank.

Source: SEBI, Kfin Technologies, Manipal Hospitals